Clinical trials
No Condition clinical trials
Below are recruiting no condition clinical trials, each written for real people, not researchers. We’re tracking 730 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT06698653Recruiting
Testing a mobility aid for lying-to-sitting transfers
This trial tests a device called SAM that helps people move from lying down to sitting up in bed. It aims to see if the device improves independence for patients who currently need help from others or equipment.
PloemeurAges 18 years+ - NCT06701851Recruiting
Brain study for movement disorder with PRRT2 gene change
This study uses brain scans to understand movement problems in people with a specific genetic change (PRRT2) that causes sudden, brief episodes of uncontrolled movements. It may help researchers find better ways to treat this condition.
ParisAges 18–75 - NCT07688278Recruiting
Diabetes screening for people with advanced gum disease
This trial tests whether checking blood sugar (HbA1c) at the dentist can find undiagnosed diabetes. It is for adults with advanced periodontitis (severe gum disease) who have not already been told they have diabetes.
SkåneAges 18 years+ - NCT07586735Recruiting
A new preparative regimen for stem cell transplant in older patients with severe aplastic anemia
This study tests a new combination of drugs to prepare older patients (40–60 years old) with severe aplastic anemia for a stem cell transplant from a half-matched donor. The goal is to make the transplant safer and more effective for this age group.
Beijing, Beijing MunicipalityAges 40–60 - NCT07548983RecruitingPhase 1
Ruxolitinib and azacitidine after stem cell transplant for acute myeloid leukemia
This trial tests whether two drugs—ruxolitinib (a JAK inhibitor) and azacitidine (a low-dose chemotherapy)—can help prevent acute myeloid leukemia from coming back after you receive a stem cell transplant from an unrelated donor. The transplant uses a gentler conditioning approach to reduce side effects while fighting the cancer.
Portland, OregonAges 18 years+ - NCT01666080Recruiting
Second bone marrow transplant with gentler chemotherapy
This trial studies a “reduced intensity” second transplant using donated blood-forming cells, for people whose first transplant did not fully and reliably restart blood production. It aims to improve donor blood cell growth while using a less harsh conditioning approach.
Minneapolis, MinnesotaAges Up to 55 years - NCT07216443RecruitingPhase 2
Study of orca-t for leukemia or MDS with reduced intensity chemo
This trial tests a new cell therapy, orca-t, given after a lower-intensity chemo and radiation regimen for people with acute myeloid leukemia, mixed phenotype leukemia, or myelodysplastic syndrome. It aims to help patients who cannot tolerate full-intensity transplant conditioning.
Los Angeles, CaliforniaAges 18 years+ - NCT07651280Recruiting
Testing AI Health Assistant Safety for the General Public
This study evaluates how well an AI system can safely answer health questions from people without medical training. Researchers want to make sure AI health assistants give reliable information to the general public.
Beijing, Beijing MunicipalityAges 18 years+ - NCT06710730Recruiting
Joy, resilience, and safety among heart surgery staff
This study surveys healthcare workers in a cardiothoracic surgery department to understand how joy, resilience, and safety culture affect their work. It aims to improve well-being and patient safety.
Oslo, OsloAges Any age - NCT06714058Recruiting
Heart risk in people with obesity
This study looks at heart health risks in people with obesity who have not had heart disease before. It aims to understand how obesity affects cardiometabolic risk factors.
Bologna, BOAges 18 years+ - NCT06717581Recruiting
Drug interaction study for older people with HIV
This study looks at how other medicines you take for conditions like high blood pressure, diabetes, or cholesterol might interact with your HIV medication (Biktarvy) if you are 60 or older. The goal is to learn how to better manage your overall health.
BolognaAges 18 years+ - NCT06721507RecruitingPhase 4
Tirzepatide after weight loss surgery
This study tests whether giving tirzepatide (a medicine that helps with weight and blood sugar) right after weight loss surgery can improve results. It is for people who are already scheduled for sleeve gastrectomy or gastric bypass at UK HealthCare.
Lexington, KentuckyAges 18 years+ - NCT06724627Recruiting
AI skin check app for walk-in clinic patients
This trial tests a smartphone-based AI system that helps diagnose skin conditions. It may offer faster, more accurate diagnosis for people visiting a walk-in clinic with a skin problem.
The Bronx, New YorkAges Any age - NCT06734273RecruitingEarly Phase 1
Sleeve gastrectomy with tirzepatide for weight loss
This trial compares getting a sleeve gastrectomy alone versus getting it along with tirzepatide (a medicine that helps with weight loss and diabetes) to see if combining them leads to more weight loss. It may help people who are having their first sleeve gastrectomy.
Chicago, IllinoisAges 18–65 - NCT06734312Recruiting
Stomach procedure to maintain weight loss after GLP-1s
This study is for people who have lost weight using semaglutide or tirzepatide and are stopping that medication. It tests a stomach procedure (called mucosal ablation) to see if it can help you keep the weight off after stopping the drug.
Cary, North CarolinaAges 21–65 - NCT06735690RecruitingEarly Phase 1
Immune cells plus vaccine after stem cell transplant for leukemia
This trial is for people with high-risk acute lymphoblastic leukemia who are getting a stem cell transplant from a family donor. After transplant, you'd receive a treatment that combines specially designed immune cells (CAR T cells) that target your leukemia, plus a vaccine that helps those cells work better.
Duarte, CaliforniaAges 18 years+ - NCT06751433RecruitingPhase 1/Phase 2
Scar gel study for preventing thick scars
This trial tests a special gel designed to prevent raised, thick scars (hypertrophic scars) after surgery or injury. If you have a new scar from a C-section, breast implant, or clean cut, this study may help reduce scarring.
Osasco, São PauloAges 18–70 - NCT06756152RecruitingPhase 2/Phase 3
Preventing GVHD after transplant for blood cancers in children and young adults
This trial tests a combination of four medicines (cyclophosphamide, abatacept, vedolizumab, and ruxolitinib) to prevent graft-versus-host disease (GVHD) after a stem cell transplant for children and young adults with certain blood cancers. The goal is to see if this approach reduces the risk of GVHD, a serious complication where donor cells attack the body.
MoscowAges 1 day–21 years - NCT06759623Recruiting
Lung function and anesthesia in bariatric surgery
This study checks how well your lungs work after you receive anesthesia (sleep medicine) for weight-loss surgery. It will help doctors choose the best anesthetic for people with obesity.
GdanskAges 18 years+ - NCT06768827Recruiting
Obesity mechanisms study for teens
This study looks at how bodies process food to understand obesity in teenagers. It may help find new ways to prevent or treat obesity.
New Haven, ConnecticutAges 15–22 - NCT06771492RecruitingPhase 3
Antibiotics for chronic back pain with Modic changes
This trial tests whether an antibiotic (amoxicillin) can reduce chronic low back pain in people who have a specific type of bone change (Modic type I) after a past herniated disc. If you qualify, you would receive either the antibiotic or a placebo (inactive pill) for several weeks.
Rotterdam, South HollandAges 18–65 - NCT06772831Recruiting
Cognitive reappraisal training for borderline personality
This study tests a thinking strategy called 'cognitive reappraisal training' for people with borderline personality disorder (BPD). The goal is to see if this training helps manage emotions and symptoms related to BPD.
New York, New YorkAges 18–55 - NCT06773871Recruiting
Exercise study for low-risk myeloid cancers and precursor conditions
This trial tests whether exercise is safe and feasible for people with low-risk myeloid cancers or certain bone marrow conditions. It aims to see if a supervised exercise program can be done without problems.
Copenhagen, DenmarkAges 18 years+ - NCT06781580Recruiting
Ergonomic program for competitive esports players
This study tests an ergonomic protocol designed to help competitive esports athletes avoid injuries and stay comfortable during long gaming sessions. It focuses on PC gamers who use a mouse and keyboard and are already on a team.
Las Vegas, NevadaAges 18 years+
Hear when a new No Condition trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for no condition?
- Yes. Clin2 currently lists 730 recruiting no condition studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a no condition trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a no condition trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.